Related Experiment Video
Updated: Sep 20, 2025

09:01
Analysis of Extracellular Vesicle-Mediated Vascular Calcification Using In Vitro and In Vivo Models
Published on: January 27, 2023
1.8K
Curcumin attenuates vascular calcification via the exosomal miR-92b-3p/KLF4 axis
Chuanzhen Chen1, Yaodong Li2, Hailin Lu1
1Department of Vascular Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning 530021, China.
Experimental Biology and Medicine (Maywood, N.J.)
|June 6, 2022
Summary
Curcumin (CUR) reduces vascular calcification by increasing exosomal miR-92b-3p, which targets KLF4. This natural compound offers a potential therapeutic strategy for vascular calcification.
Area of Science:
- Cardiovascular Biology
- Molecular Medicine
- Nanomedicine
Background:
- Vascular calcification (VC) is a prevalent pathological change in vascular diseases with poorly understood mechanisms.
- Curcumin (CUR), a natural polyphenol, exhibits cardiovascular benefits including anti-inflammatory and antioxidant effects.
- Exosomes mediate intercellular communication through their miRNA cargo, suggesting a role in VC regulation.
Purpose of the Study:
- To investigate if CUR attenuates VC by modulating exosomal miRNA secretion.
- To elucidate the molecular pathway involved in CUR's effect on VC.
Main Methods:
- In vivo and in vitro models of vascular calcification were established.
- Exosomes were isolated from vascular smooth muscle cells (VSMCs) and characterized.
- Functional assays, RT-qPCR, bioinformatics, and dual luciferase assays were employed to assess miR-92b-3p, KLF4, and RUNX2 interactions.
Main Results:
- CUR treatment and CUR-derived exosomes attenuated VSMC calcification.
- miR-92b-3p expression was upregulated in VSMCs and exosomes following CUR intervention.
- miR-92b-3p directly targeted KLF4, influencing RUNX2 expression and thereby mitigating VC in vivo and in vitro.
Conclusions:
- CUR attenuates vascular calcification through the exosomal miR-92b-3p/KLF4 signaling pathway.
- Exosomal miR-92b-3p plays a protective role against VC by downregulating KLF4 and RUNX2.
- CUR represents a promising therapeutic agent for vascular calcification.
Related Concept Videos
NF-κB-dependent Signaling Pathway
7.9K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.9K
Receptor Downregulation in MVBs
2.2K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
2.2K

